Is compounded semaglutide legit and safe
A licensed 503A or 503B pharmacy can compound semaglutide against a valid prescription, in limited circumstances set by federal law. It is never FDA-approved, and it runs about $149 to $178 a month as the cheapest legitimate route.
Compounded semaglutide runs about $149 to $178 a month, the cheapest legitimate route to the drug. A state-licensed pharmacy has to prepare it against a valid prescription, and federal rules permit that only in limited circumstances. It is not FDA-approved, because the FDA does not approve compounded drugs at all. It spread during the 2022 to 2025 semaglutide shortage, and now that semaglutide is off the shortage list, mass compounding is more restricted. Whether a product is safe depends on the pharmacy that makes it.
| Legal? | Permitted in limited circumstances, with a valid prescription filled by a 503A or 503B pharmacy. |
|---|---|
| FDA-approved? | No. The FDA does not approve any compounded drug. |
| Why it exists | The 2022 to 2025 semaglutide shortage. Now more restricted off the shortage list. |
| Safe? | Depends on the pharmacy that prepares it. |
| Red flags | "research use only," salt forms (semaglutide sodium or acetate), no US pharmacy license. |
| Cheapest legit route | About $149 to $178 a month. |
Is compounded semaglutide legal?
Only within limits set by federal law. Semaglutide is the active ingredient in Ozempic and Wegovy, both made by Novo Nordisk. A compounding pharmacy can prepare it when two things are true at once: the pharmacy holds a state license, and a licensed prescriber has written a valid prescription. The FDA recognizes two kinds. A 503A pharmacy compounds for an individual patient against that patient's prescription. A 503B outsourcing facility registers with the FDA, follows federal manufacturing standards, and makes larger batches. Both operate under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, on the FDA's human drug compounding pages. A seller that ships semaglutide with no prescriber involved is working outside that framework.
Why it is not FDA-approved
Compounded drugs are never FDA-approved, not only semaglutide but every compounded medicine. The FDA does not verify the safety, effectiveness, or quality of a compounded drug before it reaches patients. It reviews the bulk ingredients a compounder may use, plus the pharmacies and facilities themselves. So the phrase some sites use, "FDA-approved compounded semaglutide," describes something that does not exist. Ozempic and Wegovy hold FDA approval; a compounded copy does not inherit it.
What changed after the shortage ended
Wide-scale compounding was tied to a shortage. When the FDA lists a drug as in shortage, compounders gain room to make copies, because patients cannot get the approved product. Semaglutide sat on that list from 2022 into 2025. The FDA declared the shortage resolved in 2025 and set transition periods before enforcement resumed. Once a drug comes off the list, that room narrows, and 503B facilities lose most of their basis for copying a drug that is commercially available again. A 503A pharmacy can still compound a patient-specific formula when a prescriber documents a clinical reason, such as a dose change or removing an ingredient a patient cannot tolerate. That is why most legitimate compounded semaglutide today runs through 503A patient-specific compounding, not mass-produced vials sold to anyone who fills out a form.
How to spot a red-flag seller
The gap between a legitimate program and a risky one comes down to the pharmacy behind the product:
- A named US pharmacy license. A legitimate program uses a US state-licensed pharmacy and tells you which one. Confirm it with the state pharmacy board.
- A real prescription. There should be a medical intake and a licensed prescriber. No prescriber is a red flag.
- The right form of semaglutide. The FDA has warned about salt forms, semaglutide sodium and semaglutide acetate, which differ from the semaglutide base in the approved drugs. Avoid products that list a salt form.
- No "research use only" labeling. Any vial marked "research use only" or "not for human consumption" is not a medicine. It is sold to get around pharmacy law, and you have no assurance of what is in it.
If a seller cannot tell you which licensed pharmacy makes the product, treat that silence as your answer. Ask a prescriber whether compounded semaglutide fits your health situation.
What it costs
Compounded semaglutide is the cheapest legitimate route right now. Programs using licensed US pharmacies generally price it around $149 to $178 a month before any promotional discount. Brand Wegovy through Novo Nordisk's cash program costs more, and the number moves with your dose. See how the compounded programs stack up in our compounded pharmacy comparison, weigh every option on the full chart, or go straight to the cheapest GLP-1 programs.
See Strut's full score and today's price on the Strut Health review page.
This week's best deals
Some visit links earn us a commission. Disclosure